THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. (2022)
Attributed to:
Quatitative proteomic analysis of castrate-resistant prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202114764
PubMed Identifier: 35014179
Publication URI: http://europepmc.org/abstract/MED/35014179
Type: Journal Article/Review
Volume: 14
Parent Publication: EMBO molecular medicine
Issue: 3
ISSN: 1757-4676